These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2983453)

  • 21. Prostacyclin.
    Weksler BB
    Prog Hemost Thromb; 1982; 6():113-38. PubMed ID: 6762610
    [No Abstract]   [Full Text] [Related]  

  • 22. Receptors and mechanisms of action of prostacyclin in preserving non-mucosal cell integrity.
    Nicosia S; Oliva D; Paoletti R
    Gastroenterol Clin Biol; 1985; 9(12 Pt 2):33-6. PubMed ID: 2422088
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells.
    Nicosia S; Oliva D; Bernini F; Fumagalli R
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():593-9. PubMed ID: 6328938
    [No Abstract]   [Full Text] [Related]  

  • 24. Receptors for PGI2 and PGD2 on human platelets.
    Siegl AM
    Methods Enzymol; 1982; 86():179-92. PubMed ID: 6290840
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelet sensitivity to prostacyclin in smokers and non-smokers.
    Burghuber OC; Punzengruber C; Sinzinger H; Haber P; Silberbauer K
    Chest; 1986 Jul; 90(1):34-8. PubMed ID: 3522121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders.
    Cooper B; Ahern D
    J Clin Invest; 1979 Aug; 64(2):586-90. PubMed ID: 222813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostacyclin receptors of a neuronal hybrid cell line. Divalent citations and ligand-receptor coupling.
    MacDermot J; Blair IA; Cresp TM
    Biochem Pharmacol; 1981 Aug; 30(15):2041-4. PubMed ID: 6271132
    [No Abstract]   [Full Text] [Related]  

  • 28. The platelet rebound phenomenon during PGI2-infusion occurs at the receptor level.
    Steurer G; Fitscha P; Sinzinger H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):435-8. PubMed ID: 2465947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet PGI2 receptor affinity is reduced in pre-eclampsia.
    Klockenbusch W; Hohlfeld T; Wilhelm M; Somville T; Schrör K
    Br J Clin Pharmacol; 1996 Jun; 41(6):616-8. PubMed ID: 8799531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-stimulated thrombin and PDGF are normalized by insulin and Ca2+ channel blockers.
    Kahn NN
    Am J Physiol; 1999 May; 276(5):E856-62. PubMed ID: 10329979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of SQ 27,427, a thromboxane A2 receptor antagonist, in the human platelet and isolated smooth muscle.
    Harris DN; Greenberg R; Phillips MB; Michel IM; Goldenberg HJ; Haslanger MF; Steinbacher TE
    Eur J Pharmacol; 1984 Aug; 103(1-2):9-18. PubMed ID: 6090180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prostaglandin and its receptors].
    Sato M; Yasujima M; Abe K
    Nihon Rinsho; 1981 Sep; 39(9):3039-43. PubMed ID: 6279934
    [No Abstract]   [Full Text] [Related]  

  • 33. The antiaggregatory effectiveness of PGI2 and its binding to specific platelet receptors. A comparative study.
    Jaschonek K; Renn W; Weisenberger H
    Prog Clin Biol Res; 1987; 242():13-8. PubMed ID: 3313410
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
    Hanasaki K; Arita H
    Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells.
    Hall JM; Strange PG
    Biosci Rep; 1984 Nov; 4(11):941-8. PubMed ID: 6084527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationship between prostacyclin and its platelet receptor. Correlation of structure change and the platelet activity.
    Tsai AL; Wu KK
    Eicosanoids; 1989; 2(3):131-43. PubMed ID: 2517029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
    Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
    Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isoelectric and mass characterization of human platelet thromboxane A2/prostaglandin H2 receptors.
    Dorn GW
    Biochem Biophys Res Commun; 1989 Aug; 163(1):183-8. PubMed ID: 2528348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration by insulin of impaired prostaglandin E1/I2 receptor activity of platelets in acute ischemic heart disease.
    Kahn NN; Mueller HS; Sinha AK
    Circ Res; 1991 Jan; 68(1):245-54. PubMed ID: 1845854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.